Back to Search
Start Over
Correction to: An IQ consortium analysis of starting dose selection for oncology small molecule first‑in‑patient trials suggests an alternative NOAEL‑based method can be safe while reducing time to the recommended phase 2 dose.
- Source :
- Cancer Chemotherapy & Pharmacology; Sep2024, Vol. 94 Issue 3, p1-1, 1p
- Publication Year :
- 2024
- Subjects :
- CANCER chemotherapy
SMALL molecules
INTELLIGENCE levels
ONCOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 03445704
- Volume :
- 94
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Cancer Chemotherapy & Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 179815357
- Full Text :
- https://doi.org/10.1007/s00280-023-04595-8